IMMUTEP LIMITED - AMER
2.0500
07-10月-24 15:59:57
15 分の遅延
株式
0.0000
0.00%
本日の幅
2.0200 - 2.0900
ISIN
N/A
ソース
NASDAQ
-
Immutep Appoints Dr. Florian Vogl as Chief Medical Officer
26 4 2023 08:00:00 提供 Nasdaq GlobeNewswire
-
17 4 2023 09:00:00 提供 Nasdaq GlobeNewswire
-
31 3 2023 08:00:00 提供 Nasdaq GlobeNewswire
-
Immutep Announces Expansion of Triple Combination Therapy in 1st Line Non-Small Cell Lung Cancer
30 3 2023 08:00:00 提供 Nasdaq GlobeNewswire
-
23 3 2023 08:00:00 提供 Nasdaq GlobeNewswire
-
14 3 2023 08:00:01 提供 Nasdaq GlobeNewswire
-
Immutep Reaches Enrolment Target for INSIGHT-003 Trial in 1st Line NSCLC
06 2 2023 08:00:01 提供 Nasdaq GlobeNewswire
-
Immutep Quarterly Activities Report
30 1 2023 08:00:01 提供 Nasdaq GlobeNewswire
-
04 1 2023 08:00:01 提供 Nasdaq GlobeNewswire
-
23 12 2022 08:00:00 提供 Nasdaq GlobeNewswire
-
Immutep Successfully Achieves Commercial Scale in Manufacturing of Eftilagimod Alpha
08 12 2022 08:00:01 提供 Nasdaq GlobeNewswire
-
06 12 2022 08:00:01 提供 Nasdaq GlobeNewswire
-
Immutep to Participate in The JMP Securities Hematology and Oncology Summit
02 12 2022 08:00:00 提供 Nasdaq GlobeNewswire
-
Immutep Receives Australian R&D Tax Incentive
14 11 2022 08:00:01 提供 Nasdaq GlobeNewswire
-
Immutep Announces Promising Initial Clinical Data from INSIGHT-003 at SITC 2022
10 11 2022 09:00:02 提供 Nasdaq GlobeNewswire
-
09 11 2022 08:00:01 提供 Nasdaq GlobeNewswire
-
04 11 2022 08:00:00 提供 Nasdaq GlobeNewswire